Compugen (CGEN) Enterprise Value (2009 - 2026)
Compugen (CGEN) posted quarterly Enterprise Value of -$91.8 million for Q1 2026, down 29.13% year-over-year from -$129.5 million in Q1 2025, and up 32.71% on a QoQ basis from -$136.4 million in Q4 2025.
Analysis
Compugen (CGEN) Enterprise Value (2009 - 2026) Analysis & Trends
Compugen has reported Enterprise Value for 18 years, with the latest figure at -$91.8 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$91.8 million, down 29.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$91.8 million (down 29.13% YoY), and the FY2025 annual result was -$136.4 million, down 71.25% from the prior year.
- Enterprise Value advanced to -$91.8 million in Q1 2026, from -$136.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$38.9 million in Q4 2023 and troughed at -$136.4 million in Q4 2025.
- A 5-year average of -$77.0 million and a median of -$74.3 million in 2023 frame the typical range for Enterprise Value.
- The widest annual swing landed in 2023, when Enterprise Value jumped 53.28%; it then plunged 104.47% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$83.3 million in 2022, then jumped by 53.28% to -$38.9 million in 2023, then tumbled by 104.47% to -$79.6 million in 2024, then sank by 71.25% to -$136.4 million in 2025, then jumped by 32.71% to -$91.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$91.8 million in Q1 2026, -$136.4 million in Q4 2025, and -$59.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.73 Mn |
| Mar 31, 2026 | 109.65 Mn |
| Dec 31, 2025 | 8.31 Mn |
| Sep 30, 2025 | 72.26 Mn |
| Jun 30, 2025 | 94.38 Mn |
| Mar 31, 2025 | 59.68 Mn |
| Dec 31, 2024 | 57.37 Mn |
| Sep 30, 2024 | 81.95 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 161.18 Mn |
| Dec 31, 2023 | 137.75 Mn |
| Sep 30, 2023 | 32.78 Mn |
| Jun 30, 2023 | 36.77 Mn |
| Mar 31, 2023 | -13.51 Mn |
| Dec 31, 2022 | -21.35 Mn |
| Sep 30, 2022 | -31.43 Mn |
| Jun 30, 2022 | 62.61 Mn |
| Mar 31, 2022 | 171.49 Mn |
| Dec 31, 2021 | 254.61 Mn |
| Sep 30, 2021 | 397.30 Mn |